Across mice, rats, guinea pigs, and human cell experiments, CBD consistently suppressed innate immune responses — but no clinical trial has yet tested whether this translates to treating inflammatory diseases in humans.
Read this if you use CBD for an inflammatory or autoimmune condition — the preclinical evidence is genuinely promising, but you should know that no clinical trial has confirmed these effects in humans.
What the researchers found
CBD has FDA approval for epilepsy (Epidiolex), but its anti-inflammatory and immunomodulatory effects have attracted attention for conditions ranging from autoimmune diseases to COVID-19. This review cataloged what's actually known about how CBD affects the innate immune system — the body's first line of defense against pathogens and tissue damage.
The evidence base is extensive in preclinical models. Across experiments in mice, rats, guinea pigs, and human cells studied outside the body, CBD consistently reduced inflammatory responses: it decreased production of pro-inflammatory cytokines, reduced immune cell migration to sites of inflammation, and modulated the activity of macrophages, neutrophils, and natural killer cells. The effects were seen across multiple disease models, from sepsis to lung inflammation to neuroinflammation.
But here's the critical gap: as of this review, not a single clinical trial had tested CBD's immune-modulating effects in human patients with inflammatory diseases. All the evidence comes from animal models and ex vivo experiments on human cells. The translation from 'CBD reduces inflammation in a mouse' to 'CBD treats inflammatory disease in a person' remains completely untested.
The review also notes CBD's complex pharmacology — it acts through multiple receptors and pathways (CB2, GPR55, PPARγ, adenosine receptors, among others), making its immune effects difficult to predict and potentially variable depending on the disease context.
Why it matters
The disconnect between preclinical promise and clinical evidence is a defining problem in CBD research. Millions of people use CBD products for inflammatory conditions — arthritis, autoimmune diseases, chronic pain — based largely on this preclinical evidence. This review makes clear that while the laboratory evidence is genuinely promising, the clinical evidence that would actually prove benefit in humans is completely absent.
The numbers in context
CBD reduced pro-inflammatory cytokine production across multiple models. Effects were observed on macrophages, neutrophils, natural killer cells, and dendritic cells. CBD acts through CB2, GPR55, PPARγ, adenosine A2A, and TRPV1 receptors, among others. Zero clinical trials of CBD for inflammatory/immune conditions were identified as of the review date.
How the study worked
Narrative review of preclinical evidence for CBD's effects on innate immunity. Covered studies in mice, rats, guinea pigs, and ex vivo experiments on human immune cells. Examined effects on cytokine production, immune cell migration, macrophage function, neutrophil activity, and natural killer cell function across various disease models.
Who was studied
Review of preclinical evidence from various animal models and human cells.
What this study cannot tell us
Narrative review, not systematic — may not capture all relevant preclinical literature. The biggest limitation is the one the authors themselves emphasize: no clinical trials exist. Animal immune responses differ from human ones in important ways, and many drugs that work brilliantly in mice fail in humans. The multi-receptor pharmacology of CBD means that immune effects observed in one context may not apply to others.
How to read the evidence
Narrative review of preclinical evidence. The animal and cell data are extensive and consistent, but the complete absence of clinical trials makes the evidence preliminary by definition. This is a hypothesis-generating review, not clinical guidance.
When this study was published
Published in 2023. Clinical trials testing CBD in inflammatory conditions may now be underway or recently completed.
The bigger picture
This review provides the immunological backdrop for several studies in the RethinkTHC database. The CBG inflammation study (RTHC-00097) works through partly overlapping pathways (TRPA1). The CBD drug interaction study (RTHC-00091) showed CBD's effects on liver enzymes, which is relevant because immune-modulating doses of CBD might also affect how patients metabolize other medications. The gap between preclinical promise and clinical evidence is a theme that runs through much of cannabis research.
Replication
Not stated in abstract.
Funding
Not reported in abstract.
Conflicts of interest
Not reported in abstract.
Questions still open
- Will CBD's immunosuppressive effects translate to clinical benefit in autoimmune diseases, or will they increase infection risk? At what doses do immune effects occur, and how do those compare to typical consumer CBD product doses? Could CBD's immune-modulating effects be harmful in some contexts (like during acute infections) even as they're helpful in others (like autoimmune flares)?
Read the original research
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance.
International journal of molecular sciences, 24(4)
The International Journal of Molecular Sciences is a reputable peer-reviewed journal focusing on molecular biology and related fields.
Citation
Martini, Stefano; Gemma, Alessandra; Ferrari, Marco; Cosentino, Marco; Marino, Franca. (2023). Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance.. International journal of molecular sciences, 24(4). https://doi.org/10.3390/ijms24043125
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk